| 臺大學術典藏 |
2020-06-16T07:53:23Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.;Hou H.-A.;Tang J.-L.;Kuo Y.-Y.;Chen C.-Y.;Tsai C.-H.;Yao M.;Lin C.-T.;Li C.-C.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Liu J.-H.;Chou S.-C.;Tsay W.;Tseng M.-H.;Liu M.-C.;Liu C.-W.;Liang-In Lin;Chou W.-C.;Tien H.-F.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Chen C.-Y.; CHENG-HONG TSAI; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y. |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; MING YAO; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-12T12:53:48Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; SHANG-YI HUANG; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-22T03:35:55Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; LIU JIA-HAU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:17Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; HSIN-AN HOU; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
FENG-MING TIEN; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 國立成功大學 |
2016-11-12 |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou, Jyh-Ming;Fang, Yu-Jen;Chen, Chieh-Chang;Bair, Ming-Jong;Chang, Chi-Yang;Lee, Yi-Chia;Chen, Mei-Jyh;Chen, Chien-Chuan;Tseng, Cheng-Hao;Hsu, Yao-Chun;Lee, Ji-Yuh;Yang, Tsung-Hua;Luo, Jiing-Chyuan;Chang, Chun-Chao;Chen, Chi-Yi;Chen, Po-Yueh;Shun, Chia-Tung;Hsu, Wen-Feng;Hu, Wen-Hao;Chen, Yen-Nien;Sheu, Bor-Shyang;Lin, Jaw-Town;Wu, Jeng-Yih;El-Omar, Emad M.;Wu, Ming-Shiang |
| 國立臺灣大學 |
2016 |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou, Jyh-Ming; Fang, Yu-Jen; Chen, Chieh-Chang; Bair, Ming-Jong; Chang, Chi-Yang; Lee, Yi-Chia; Chen, Mei-Jyh; Chen, Chien-Chuan; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; Shun, Chia-Tung; Hsu, Wen-Feng; Hu, Wen-Hao; Chen, Yen-Nien; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M.; Wu, Ming-Shiang; 許文峰; 胡文皓; 林肇堂; 陳美志; 吳明修; 李宜家; 李基裕; 劉志銘; 孫家棟; 吳明賢; 陳建全; 方佑仁; 陳介章 |
| 臺大學術典藏 |
2018-09-10T15:37:40Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou, Jyh-Ming;Fang, Yu-Jen;Chen, Chieh-Chang;Bair, Ming-Jong;Chang, Chi-Yang;Lee, Yi-Chia;Chen, Mei-Jyh;Chen, Chien-Chuan;Tseng, Cheng-Hao;Hsu, Yao-Chun;Lee, Ji-Yuh;Yang, Tsung-Hua;Luo, Jiing-Chyuan;Chang, Chun-Chao;Chen, Chi-Yi;Chen, Po-Yueh;Shun, Chia-Tung;Hsu, Wen-Feng;Hu, Wen-Hao;Chen, Yen-Nien;Sheu, Bor-Shyang;Lin, Jaw-Town;Wu, Jeng-Yih;El-Omar, Emad M.;Wu, Ming-Shiang; Liou, J.-M. and Fang, Y.-J. and Chen, C.-C. and Bair, M.-J. and Chang, C.-Y. and Lee, Y.-C. and Chen, M.-J. and Chen, C.-C. and Tseng, C.-H. and Hsu, Y.-C. and Lee, J.-Y. and Yang, T.-H. and Luo, J.-C. and Chang, C.-C. and Chen, C.-Y. and Chen, P.-Y. and Shun, C.-T. and Hsu, W.-F. and Hu, W.-H. and Chen, Y.-N. and Sheu, B.-S. and Lin, J.-T. and Wu, J.-Y. and El-Omar, E.M. and Wu, M.-S.; 許文峰;胡文皓;林肇堂;陳美志;吳明修;李宜家;李基裕;劉志銘;孫家棟;吳明賢;陳建全;方佑仁;陳介章; WEN-FENG HSU; Liou, Jyh-Ming; WEN-HAO HU; Fang, Yu-Jen; Chen, Chieh-Chang; JYH-MING LIOU; Bair, Ming-Jong; YI-CHIA LEE; MING-SHIANG WU; Chang, Chi-Yang; Lee, Yi-Chia; Chen, Mei-Jyh; Chen, Chien-Chuan; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; Shun, Chia-Tung; Hsu, Wen-Feng; Hu, Wen-Hao; Chen, Yen-Nien; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M.; Wu, Ming-Shiang |
| 臺大學術典藏 |
2020-11-02T02:04:25Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-27T03:28:37Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T05:45:15Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.;Fang Y.-J.;Chen C.-C.;Bair M.-J.;Chang C.-Y.;Yi-Chia Lee;Chen M.-J.;Chen C.-C.;Tseng C.-H.;Hsu Y.-C.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Chang C.-C.;Chen C.-Y.;Chen P.-Y.;Shun C.-T.;Hsu W.-F.;Hu W.-H.;Chen Y.-N.;Sheu B.-S.;Lin J.-T.;Wu J.-Y.;El-Omar E.M.;Wu M.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-03-18T02:02:34Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-10-18T06:30:00Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; YEN-NIEN CHEN; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:58Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; WEN-FENG HSU; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:04Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEN-CHUAN CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:08Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-18T08:38:05Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chieh-Chang Chen; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:53Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 義守大學 |
2012-01 |
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract
|
Wen-Lun Wang;Wei-Lun Chang;Yi-Chun Yeh;Ching-Tai Lee;Chi-Yang Chang;Jaw-Town Lin;Bor-Shyang Sheu |
| 國立成功大學 |
2013-06 |
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract
|
Wang, Wen-Lun; Chang, Wei-Lun; Yeh, Yi-Chun; Lee, Ching-Tai; Chang, Chi-Yang; Lin, Jaw-Town; Sheu, Bor-Shyang |
| 臺北醫學大學 |
2010-02-11 |
Concor / 康肯錠
|
藥劑部藥師 |
| 淡江大學 |
2006-08 |
Concordance and Discrepancy between Electrodiagnosis and Magnetic Resonance Imaging in Cervical Root Avulsion Injuries
|
Tsai, Po-yi; Chuang, Tien-yow; Cheng, Henrich; Wu, Hsiu-mei; 張玉坤; Chang, Yue-cune; Wang, Chih-pin |
| 臺大學術典藏 |
2020-02-06T06:49:52Z |
Concordance between different trophectoderm biopsy sites and the inner cell mass of chromosomal composition measured with a next-generation sequencing platform
|
Chuang T.-H;Hsieh J.-Y;Lee M.-J;Lai H.-H;Hsieh C.-L;Wang H.-L;Chang Y.-J;Shee-Uan Chen; Chuang T.-H; Hsieh J.-Y; Lee M.-J; Lai H.-H; Hsieh C.-L; Wang H.-L; Chang Y.-J; SHEE-UAN CHEN |
| 臺大學術典藏 |
2020-02-05T05:10:56Z |
Concordance between genetic diversity and marine biogeography in a highly mobile marine mammal, the Risso's dolphin
|
Chen I.;Nishida S.;Chou L.-S.;Tajima Y.;Yang W.-C.;Isobe T.;Yamada T.K.;Hartman K.;Hoelzel A.R.; Chen I.; Nishida S.; Chou L.-S.; Tajima Y.; Yang W.-C.; Isobe T.; Yamada T.K.; Hartman K.; Hoelzel A.R.; LIEN-SIANG CHOU |
| 國立成功大學 |
2015-05-01 |
Concordance Between Patient and Clinician Assessment of Dry Eye Severity and Treatment Response in Taiwan
|
Yeh, Po-Ting; Chien, Hsu-Chih; Ng, Kwong; Tseng, Sung-Huei; Chen, Wei-Li; Hou, Yu-Chih; Wang, I-Jong; Chu, Hsiao-Sung; Yang, Yea-Huei Kao; Hu, Fung-Rong |
| 臺大學術典藏 |
2015 |
Concordance between patient and clinician assessment of dry eye severity and treatment response in Taiwan
|
Yeh P.-T.; Chien H.-C.; Ng K.; Tseng S.-H.; WEI-LI CHEN; Hou Y.-C.; Wang I.-J.; Chu H.-S.; Yang Y.-H.K.; Hu F.-R. |
| 臺大學術典藏 |
2020-11-27T05:43:27Z |
Concordance between patient and clinician assessment of dry eye severity and treatment response in Taiwan
|
Yeh P.-T.; Chien H.-C.; Ng K.; Tseng S.-H.; Chen W.-L.; YU-CHIH HOU; Wang I.-J.; Chu H.-S.; Yang Y.-H.K.; Hu F.-R. |
| 臺大學術典藏 |
2022-07-15T08:17:31Z |
Concordance between patient and clinician assessment of dry eye severity and treatment response in Taiwan
|
Yeh P.-T.; Chien H.-C.; Ng K.; Tseng S.-H.; Chen W.-L.; Hou Y.-C.; Wang I.-J.; Chu H.-S.; Yang Y.-H.K.; FUNG-RONG HU |
| 臺大學術典藏 |
2022-07-20T06:33:50Z |
Concordance between patient and clinician assessment of dry eye severity and treatment response in Taiwan
|
PO-TING YEH; Chien H.-C.; Ng K.; Tseng S.-H.; Chen W.-L.; Hou Y.-C.; Wang I.-J.; Chu H.-S.; Yang Y.-H.K.; Hu F.-R. |
| 國家衛生研究院 |
2014-12-02 |
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan
|
Wu, CS;Lai, MS;Gau, SSF;Wang, SC;Tsai, HJ |
| 臺大學術典藏 |
2022-09-02T02:56:41Z |
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan
|
Tsai H.-J.; SUSAN SHUR-FEN GAU; Wang S.-C.; Lai M.-S.; Wu C.-S. |
| 臺大學術典藏 |
2018-09-10T15:00:49Z |
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan
|
Wu, C.-S. and Lai, M.-S. and Gau, S.S.-F. and Wang, S.-C. and Tsai, H.-J.; SUSAN SHUR-FEN GAU; CHI-SHIN WU |
| 臺大學術典藏 |
2020-03-02T03:11:02Z |
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan
|
Wu C.-S.; Lai M.-S.; SUSAN SHUR-FEN GAU; Wang S.-C.; Tsai H.-J. |
| 臺大學術典藏 |
2014 |
Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan
|
CHI-SHIN WU; Lai M.-S.; Gau S.S.-F.; Wang S.-C.; Tsai H.-J. |
| 國立高雄師範大學 |
2005-12 |
Concordance of physical activity among parents and youth with physical disabilities
|
Chien-Yu Pan;Georgia C. Frey;Oded Bar-Or;Patricia Longmuir; 潘倩玉 |
| 臺大學術典藏 |
1997 |
Concordance of Positive and Negative Symptoms in Coaffected Sib-Pairs with Schizophrenia
|
Hwu, Hai-Gwo;陳為堅; HWU, HAI-GWO;WU, YUAN-CHING;LEE, SANDY, F-C;YEH, LING-LING;GWO, SHI-CHIN;HSU, HEY-CHI;CHANG, CHING-JUI;CHEN, WEI-JANE; 胡海國;吳元欽;李鳳墀;葉玲玲;郭錫卿;許輝吉;張景瑞;陳為堅; HWU, HAI-GWO; 陳為堅 |
| 亞洲大學 |
2009 |
Concordance of positive and negative symptoms in coaffected sib-pairs with schizophrenia
|
葉玲玲(Ling-Ling Yeh) |
| 國立臺灣大學 |
1997 |
Concordance of Positive and Negative Symptoms in Coaffected Sib-Pairs with Schizophrenia
|
胡海國; 吳元欽; 李鳳墀; 葉玲玲; 郭錫卿; 許輝吉; 張景瑞; 陳為堅; HWU, HAI-GWO; WU, YUAN-CHING; LEE, SANDY, F-C; YEH, LING-LING; GWO, SHI-CHIN; HSU, HEY-CHI; CHANG, CHING-JUI; CHEN, WEI-JANE |
| 臺大學術典藏 |
2022-05-05T05:16:38Z |
Concordance of positive and negative symptoms in coaffected sib-pairs with schizophrenia
|
Hwu H.-G.; Wu Y.-C.; Lee S.F.-C.; Yeh L.-L.; Gwo S.-C.; Hsu H.-C.; Chang C.-J.; WEI J. CHEN |
| 國立臺灣大學 |
1997 |
CONCORDANCE OF POSITIVE AND NEGATIVE SYMPTOMS IN COAFFECTED SIB-PAIRS WITH SCHIZOPHRENIA.
|
CHEN, WEI-JANE; HWU, HAI-GWO; WU, YUAN-CHING; YEH, LING-LING; GWO, SHI-CHIN; CHANG, CHING-JUI; 陳為堅; 胡海國; 吳元欽; 葉玲玲; 郭錫卿; 張景瑞 |
| 國立臺灣大學 |
2005 |
CONCORDANCE OF PREFERENCES FOR END- OF-LIFE CARE BETWEEN TERMINALLY ILL CANCER PATIENTS AND THEIR FAMILY CAREGIVERS IN TAIWAN
|
TANG, SIEW-TZUH; LIU, TSANG-WU; LAI, MEI-SHU; LIU, LI-NIUH; 唐秀治; 劉滄梧; 賴美淑; 劉莉妮 |
| 國家衛生研究院 |
2005-12 |
Concordance of preferences for end-of-life care between terminally ill cancer patients and their family caregivers in Taiwan
|
Tang, ST;Liu, TW;Lai, MS;Liu, LN;Chen, CH |
| 國立臺灣大學 |
2005-12 |
Concordance of Preferences for End-of-Life Care Between Terminally Ill Cancer Patients and Their Family Caregivers in Taiwan
|
Tang, Siew-Tzuh; Liu, Tsang-Wu; Lai, Mei-Shu; Liu, Li-Ni; Chen, Chen-Hsiu |
| 臺大學術典藏 |
2020-12-25T09:42:48Z |
Concordance-based estimation approaches for the optimal sufficient dimension reduction score
|
CHIN-TSANG CHIANG; Chiang, C.-T.; Wang, S.-H.; Wang, S.-H.;Chiang, C.-T. |
